STAT+: A new biotech tries to bridge the drug innovation gap between East and West
A growing number of Chinese biotech companies are trying to bridge the drug innovation gap between the East and the West. Now, Overland Pharmaceuticals is joining the fray.
The company, which launched earlier this month, is backed by Hillhouse Capital and will be led by co-founders Hua Mu and Ed Zhang, two venture partners who joined the Asia-focused private equity group earlier this year.
Continue to STAT+ to read the full story…
